Reprint

Molecules at Play in Cancer

Edited by
April 2023
366 pages
  • ISBN978-3-0365-7303-8 (Hardback)
  • ISBN978-3-0365-7302-1 (PDF)

This book is a reprint of the Special Issue Molecules at Play in Cancer that was published in

Biology & Life Sciences
Summary

"Molecules at Play in Cancer" is a collection of 24 research articles on recent findings about some important molecules responsible for either cancer development and proliferation, or anti-cancer therapy. It covers a wide range of tissues and organs affected by cancer: adrenal glands, blood, breasts, muscles, ovaries, prostate, stomach, and testicles.

Format
  • Hardback
License
© 2022 by the authors; CC BY-NC-ND license
Keywords
Agkistrodon; leucine; membrane; phenylalanine; venom peptides; familial hyperaldosteronism type 3; KCNJ5; adrenal tumor; β-catenin; MALDI-IMS; CYP11B2; PNU-74654; TNF receptor-1; apoptosis; testicular cancer; alveolar epithelial stem cells; ACE2; SARS-CoV-2; COVID-19; RBD of spike glycoprotein; metastatic microenvironment; ovarian cancer; exosomal microRNA; biomarker; early diagnosis; BSG; basigin; CD147; MM; multiple myeloma; survival; AP5M1; BAIAP2L1; CRISPR; ENTPD2; master regulator; LOC145474; MTOR; PRRG1; VIM; WFDC3; circulating tumor cells; non-small-cell lung cancer; single cell next generation sequencing; nematode; microenvironment; cancer; research; ovarian cancer; ZEB2; prognosis; biomarker; immune cells; cyclin D1; epidermal growth factor receptor (EGFR); stage I gastric cancer; early gastric cancer; node-negative gastric cancer; B-cell maturation antigen (BCMA); soluble BCMA (sBCMA); multiple myeloma (MM); anti-BCMA CAR-T cell therapy; INDEL; cancer; genetic ancestry; Amazon; biomarkers; KIRC; GOT2; multi-omics; epigenetics; immune cell infiltration; arsenic trioxide; Parkin; HeLa; apoptosis; autophagy; salivaomics; breast cancer; biomarkers; saliva; molecular biological subtype; HER2 status; estrogen receptors; progesterone receptors; HPV DNA in breast; nested PCR; breast cancer; gastric cancer; prognosis; biomarker; hsa-miR-942-3p; AR; MAPK/ERK signaling pathway; HCC; CTCs; miRNAs; proteomics; fenbendazole; microtubule polymerization; self-administration; cancer; EMT; UQCRB; ROS; hypoxia; HIF-1α; deuterium-depleted water (DDW); deuterium-depleted yolk (DDyolk); anticancer drug development; D/H ratio; production of metabolic water; ketogenic diet; NEAT1; liver cancer cell line; drug resistance; SOD2; MAPK; AKT; rhabdomyosarcoma; sarcoma; cancer; mouse model; Nf1; Ink4a/Arf; vincristine; n/a